Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter

A cross-sectional study

Mihály Sulyok, Mihály Makara, Zsófia Rupnik, Tamás Ferenci, E. Újhelyi, Luca Kormos, Zsuzsanna Gerlei, János Szlávik, Gábor Horváth, István Vályi-Nagy

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives Available data on the prevalence of hepatic steatosis in an unselected HIV-infected population are limited. The aim of this study was to determine the prevalence of hepatic steatosis and assess the associated factors in HIV-infected individuals. Patients and methods One hundred and thirty-six HIV-infected individuals were enrolled in this cross-sectional study. Patients underwent transient elastography and controlled attenuation parameter (CAP) measurements. We analyzed the associations between the CAP value and demographic, metabolic, and immunologic parameters. For the first time, in HIV-infected individuals, we used a continuous scale of CAP values to identify significant covariates of hepatic fat accumulation. As a result and compared with other methods, one of the main advantages of CAP was that the quantitative measurement of liver steatosis could be used for analysis. Results Using univariate analysis, CAP was significantly correlated with the following continuous variables: CD4 percentage (P=0.035), CD8 percentage (P=0.016), age (P

Original languageEnglish
Pages (from-to)679-685
Number of pages7
JournalEuropean Journal of Gastroenterology and Hepatology
Volume27
Issue number6
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Cross-Sectional Studies
HIV
Liver
Elasticity Imaging Techniques
Fatty Liver
Fats
Demography
Population

Keywords

  • elasticity imaging techniques
  • fatty liver
  • HIV infections
  • multivariate analysis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology
  • Medicine(all)

Cite this

Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter : A cross-sectional study. / Sulyok, Mihály; Makara, Mihály; Rupnik, Zsófia; Ferenci, Tamás; Újhelyi, E.; Kormos, Luca; Gerlei, Zsuzsanna; Szlávik, János; Horváth, Gábor; Vályi-Nagy, István.

In: European Journal of Gastroenterology and Hepatology, Vol. 27, No. 6, 01.12.2015, p. 679-685.

Research output: Contribution to journalArticle

Sulyok, Mihály ; Makara, Mihály ; Rupnik, Zsófia ; Ferenci, Tamás ; Újhelyi, E. ; Kormos, Luca ; Gerlei, Zsuzsanna ; Szlávik, János ; Horváth, Gábor ; Vályi-Nagy, István. / Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter : A cross-sectional study. In: European Journal of Gastroenterology and Hepatology. 2015 ; Vol. 27, No. 6. pp. 679-685.
@article{2d4bcfef6833483295967c0576476a14,
title = "Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: A cross-sectional study",
abstract = "Objectives Available data on the prevalence of hepatic steatosis in an unselected HIV-infected population are limited. The aim of this study was to determine the prevalence of hepatic steatosis and assess the associated factors in HIV-infected individuals. Patients and methods One hundred and thirty-six HIV-infected individuals were enrolled in this cross-sectional study. Patients underwent transient elastography and controlled attenuation parameter (CAP) measurements. We analyzed the associations between the CAP value and demographic, metabolic, and immunologic parameters. For the first time, in HIV-infected individuals, we used a continuous scale of CAP values to identify significant covariates of hepatic fat accumulation. As a result and compared with other methods, one of the main advantages of CAP was that the quantitative measurement of liver steatosis could be used for analysis. Results Using univariate analysis, CAP was significantly correlated with the following continuous variables: CD4 percentage (P=0.035), CD8 percentage (P=0.016), age (P",
keywords = "elasticity imaging techniques, fatty liver, HIV infections, multivariate analysis",
author = "Mih{\'a}ly Sulyok and Mih{\'a}ly Makara and Zs{\'o}fia Rupnik and Tam{\'a}s Ferenci and E. {\'U}jhelyi and Luca Kormos and Zsuzsanna Gerlei and J{\'a}nos Szl{\'a}vik and G{\'a}bor Horv{\'a}th and Istv{\'a}n V{\'a}lyi-Nagy",
year = "2015",
month = "12",
day = "1",
doi = "10.1097/MEG.0000000000000339",
language = "English",
volume = "27",
pages = "679--685",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter

T2 - A cross-sectional study

AU - Sulyok, Mihály

AU - Makara, Mihály

AU - Rupnik, Zsófia

AU - Ferenci, Tamás

AU - Újhelyi, E.

AU - Kormos, Luca

AU - Gerlei, Zsuzsanna

AU - Szlávik, János

AU - Horváth, Gábor

AU - Vályi-Nagy, István

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Objectives Available data on the prevalence of hepatic steatosis in an unselected HIV-infected population are limited. The aim of this study was to determine the prevalence of hepatic steatosis and assess the associated factors in HIV-infected individuals. Patients and methods One hundred and thirty-six HIV-infected individuals were enrolled in this cross-sectional study. Patients underwent transient elastography and controlled attenuation parameter (CAP) measurements. We analyzed the associations between the CAP value and demographic, metabolic, and immunologic parameters. For the first time, in HIV-infected individuals, we used a continuous scale of CAP values to identify significant covariates of hepatic fat accumulation. As a result and compared with other methods, one of the main advantages of CAP was that the quantitative measurement of liver steatosis could be used for analysis. Results Using univariate analysis, CAP was significantly correlated with the following continuous variables: CD4 percentage (P=0.035), CD8 percentage (P=0.016), age (P

AB - Objectives Available data on the prevalence of hepatic steatosis in an unselected HIV-infected population are limited. The aim of this study was to determine the prevalence of hepatic steatosis and assess the associated factors in HIV-infected individuals. Patients and methods One hundred and thirty-six HIV-infected individuals were enrolled in this cross-sectional study. Patients underwent transient elastography and controlled attenuation parameter (CAP) measurements. We analyzed the associations between the CAP value and demographic, metabolic, and immunologic parameters. For the first time, in HIV-infected individuals, we used a continuous scale of CAP values to identify significant covariates of hepatic fat accumulation. As a result and compared with other methods, one of the main advantages of CAP was that the quantitative measurement of liver steatosis could be used for analysis. Results Using univariate analysis, CAP was significantly correlated with the following continuous variables: CD4 percentage (P=0.035), CD8 percentage (P=0.016), age (P

KW - elasticity imaging techniques

KW - fatty liver

KW - HIV infections

KW - multivariate analysis

UR - http://www.scopus.com/inward/record.url?scp=84957638076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957638076&partnerID=8YFLogxK

U2 - 10.1097/MEG.0000000000000339

DO - 10.1097/MEG.0000000000000339

M3 - Article

VL - 27

SP - 679

EP - 685

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 6

ER -